APA (7th ed.) Citation

A, J., X, L., S, H., WJ, L., H, Y., A, T., . . . DG, T. (2025). Cell-resolved high-dimensional imaging analysis, therapeutic modeling, and a Phase Ib clinical study establish BCL-2 as a target across heterogeneous CRPC subtypes. BioRxiv : the preprint server for biology. https://doi.org/10.1101/2025.07.08.663739

Chicago Style (17th ed.) Citation

A, Jamroze, et al. "Cell-resolved High-dimensional Imaging Analysis, Therapeutic Modeling, and a Phase Ib Clinical Study Establish BCL-2 as a Target Across Heterogeneous CRPC Subtypes." BioRxiv : The Preprint Server for Biology 2025. https://doi.org/10.1101/2025.07.08.663739.

MLA (9th ed.) Citation

A, Jamroze, et al. "Cell-resolved High-dimensional Imaging Analysis, Therapeutic Modeling, and a Phase Ib Clinical Study Establish BCL-2 as a Target Across Heterogeneous CRPC Subtypes." BioRxiv : The Preprint Server for Biology, 2025, https://doi.org/10.1101/2025.07.08.663739.